A Modular Approach to the ECVAM Principles on Test Validity
暂无分享,去创建一个
Valérie Zuang | Andrew Worth | Silvia Casati | Raffaella Corvi | Sebastian Hoffmann | Thomas Hartung | Sandra Coecke | Marlies Halder | Laura Gribaldo | Susanne Bremer | Salvador Fortaner | Laurie Scott | Annett Janusch Roi | A. Worth | T. Hartung | L. Gribaldo | S. Bremer | S. Hoffmann | R. Corvi | E. Sabbioni | S. Coecke | V. Zuang | M. Halder | S. Casati | Enrico Sabbioni | S. Fortaner | A. Roi | P. Prieto | Laurie Scott | Pilar Prieto | Andrew Paul Worth
[1] Robert D. Combes,et al. Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .
[2] Michael Balls,et al. ECVAM Good Cell Culture Practice Task Force Report 1 , 2002, Alternatives to laboratory animals : ATLA.
[3] Spielmann Horst,et al. Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .
[4] A P Worth,et al. The Role of ECVAM in Promoting the Regulatory Acceptance of Alternative Methods in the European Union , 2001, Alternatives to laboratory animals : ATLA.
[5] Andrew Worth,et al. ECVAM's Response to the Changing Political Environment for Alternatives: Consequences of the European Union Chemicals and Cosmetics Policies , 2003, Alternatives to laboratory animals : ATLA.
[6] Michael Balls,et al. The Role of Prevalidation in the Development, Validation and Acceptance of Alternative Methods , 1995 .
[7] M Liebsch,et al. The ECVAM Prevalidation Study on the Use of EpiDerm for Skin Corrosivity Testing , 2000, Alternatives to laboratory animals : ATLA.
[8] ICCVAM Guidelines for the Nomination and Submission of New, Revised, and Alternative Test Methods , 2003 .
[9] Michael Balls. Defined Structural and Performance Criteria would Facilitate the Validation and Acceptance of Alternative Test Procedures , 1997 .